Skip to main content
SpringerLink
Log in

No increased risk of serious asthma with salmeterol/fluticasone

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. long-acting β-agonists

References

  1. Stempel DA, et al. Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone. New England Journal of Medicine : 6 Mar 2016. Available from: URL: http://dx.doi.org/10.1056/NEJMoa1511049

    PubMed  Google Scholar 

  2. Martinez FD. Safety of Fluticasone plus Salmeterol in Asthma - Reassuring Data, but No Final Answer. New England Journal of Medicine : 6 Mar 2016. Available from: URL: http://dx.doi.org/10.1056/NEJMe1601040

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

No increased risk of serious asthma with salmeterol/fluticasone. Reactions Weekly 1593, 11 (2016). https://doi.org/10.1007/s40278-016-15654-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-15654-6

Search

Navigation